RhoFED AA-SCCC
RhoFED AA-SCCC
基本信息
- 批准号:10746035
- 负责人:
- 金额:$ 919.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-05 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:Adverse eventAllergic DiseaseArchivesAsthmaBiologicalBiological Specimen BanksClinicalClinical DataClinical InvestigatorClinical ProtocolsClinical ResearchClinical Trials Data Monitoring CommitteesClinical Trials DesignCollaborationsCommunicationContractorCredentialingDataDatabasesDedicationsDevelopmentEnsureEquipment and supply inventoriesEthicsExtrinsic asthmaFundingFunding OpportunitiesHealth Service AreaHuman ResourcesHypersensitivityInfrastructureInternetLeadershipManuscriptsMethodologyMissionModernizationMonitorNational Institute of Allergy and Infectious DiseaseObservational StudyParticipantPerformancePersonsPreparationPrevention strategyProcessProtocols documentationQuality ControlReportingResearchResearch DesignResearch PersonnelResearch SupportResource SharingResourcesSafetySafety ManagementSamplingScientific EvaluationScientistSecureServicesSiteSpecimenStandardizationStatistical Data InterpretationStructureSystemTechniquesTechnologyTrainingU-Series Cooperative AgreementsUnited StatesWorkWritingbiobankclinical research sitecostdashboarddata managementdata sharingdesignexperienceflexibilityimprovedinnovationinsightnovel therapeutic interventionpatient safetypharmacovigilancepreventprogramsprotocol developmentquality assurancerepositoryresearch studyrhoskillstoolweb pageweb portal
项目摘要
PROJECT SUMMARY/ABSTRACT
The cooperative agreement funded by this Funding Opportunity Announcement establishes an Asthma and
Allergy Statistical and Clinical Coordinating Center (AA-SCCC), which will further NIAID’s mission to support
clinical research aimed at developing new or improved strategies to treat or prevent allergic diseases and
asthma. The objective of the AA-SCCC is to provide excellent and efficient coordination of the following
services: protocol development, study initiation and management, statistical design and analysis, and
biological specimen repository management. To accomplish these objectives, Rho aims to (1) provide staff
experienced in research conducted by NIAID-supported research networks and to organize these staff in an
administrative structure that manages resources efficiently, is responsive to the needs of the research
networks and NIAID, and facilitates communication and collaboration; (2) provide experienced scientists and
statisticians who, in collaboration with clinical investigators and NIAID officials, design and analyze studies
across the full scope of research; (3) facilitate the development, review, and revision of research protocols and
protocol-related documents through dedicated protocol teams; (4) provide study initiation and study
management functions that are required for the efficient, valid, and ethical conduct of studies; (5) continuously
monitor the accuracy and completeness of research data; (6) help ensure patient safety by providing high-
quality adverse event surveillance and Data and Safety Monitoring Board (DSMB) reports; (7) provide for
secure storage of biospecimens, along with their distribution for innovative mechanistic research; and (8)
effectively collaborate with the other components of the NIAID clinical research program, e.g. the NIAID
Regulatory Management Center (RMC), the Clinical Data and Safety Management Center (CDSMC), the
Clinical Site Monitoring Center (CSMC), and the Clinical Products Center (CPC).
Based on more than 25 years of experience coordinating all aspects of clinical research in asthma and allergic
diseases, we will use our current technology infrastructure, combined with new and innovative techniques to:
streamline and automate processes; provide easy access to data for DAIT, clinical investigators, and other key
research stakeholders; allow for flexibility of staffing and resource sharing; standardize processes and
methodologies across research networks where practicable; and continue to provide the flexibility necessity to
meet the changing demands of this dynamic research program.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gloria David其他文献
Gloria David的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gloria David', 18)}}的其他基金
Rho Federal Systems Division, Inc. NIAID DAIT SACCC
Rho 联邦系统部, Inc. NIAID DAIT SACCC
- 批准号:
10364588 - 财政年份:2021
- 资助金额:
$ 919.2万 - 项目类别:
Rho Federal Systems Division, Inc. NIAID DAIT SACCC
Rho 联邦系统部, Inc. NIAID DAIT SACCC
- 批准号:
10823519 - 财政年份:2015
- 资助金额:
$ 919.2万 - 项目类别:
Rho Federal Systems Division, Inc. NIAID DAIT SACCC
Rho 联邦系统部, Inc. NIAID DAIT SACCC
- 批准号:
10589242 - 财政年份:2015
- 资助金额:
$ 919.2万 - 项目类别:
相似海外基金
Elucidating the Role of Cutaneous Environmental Factors in the Development of Allergic Disease
阐明皮肤环境因素在过敏性疾病发展中的作用
- 批准号:
10664255 - 财政年份:2023
- 资助金额:
$ 919.2万 - 项目类别:
Regulatory mechanism of allergic disease development by inhibitory co-receptors
抑制性共受体对过敏性疾病发生的调控机制
- 批准号:
22H02888 - 财政年份:2022
- 资助金额:
$ 919.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10633229 - 财政年份:2022
- 资助金额:
$ 919.2万 - 项目类别:
Deep Phenotyping of Allergic Disease and Environmental Allergen Component Sensitization
过敏性疾病的深层表型分析和环境过敏原成分致敏
- 批准号:
22K10545 - 财政年份:2022
- 资助金额:
$ 919.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
- 批准号:
10670058 - 财政年份:2022
- 资助金额:
$ 919.2万 - 项目类别:
Elucidation of immune and allergic disease dynamics by integrative sequencing analysis
通过整合测序分析阐明免疫和过敏性疾病动态
- 批准号:
22H00476 - 财政年份:2022
- 资助金额:
$ 919.2万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
- 批准号:
10353468 - 财政年份:2022
- 资助金额:
$ 919.2万 - 项目类别:
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10535286 - 财政年份:2022
- 资助金额:
$ 919.2万 - 项目类别:
Humoral Immunoregulation of Allergic Disease by Follicular T Cell Subsets
滤泡 T 细胞亚群对过敏性疾病的体液免疫调节
- 批准号:
10570227 - 财政年份:2021
- 资助金额:
$ 919.2万 - 项目类别:
Investigating the effect of maternal microbiome on fetal hematopoiesis and subsequent susceptibility to allergic disease
研究母体微生物组对胎儿造血和随后对过敏性疾病的易感性的影响
- 批准号:
467169 - 财政年份:2021
- 资助金额:
$ 919.2万 - 项目类别:
Studentship Programs